Ameritas Investment Partners, Inc.

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1055980 LINCOLN, NE

Position in BMRN

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$1,999,294

-$93,117 QoQ

Shares Held

35,392

+0.5% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Ameritas Investment Partners, Inc. holds $51,229,251 across 215 Biotechnology names. BMRN ranks #8 (3.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	12,563	$5,609,881
2	REGN	Regeneron Pharmaceuticals, Inc.	4,656	$3,597,411
3	EXEL	Exelixis, Inc.	70,554	$3,026,060
4	ARWR	Arrowhead Pharmaceuticals, Inc.	36,974	$2,318,269
5	ROIV	Roivant Sciences Ltd.	83,064	$2,300,872
6	CYTK	Cytokinetics Inc	32,284	$2,127,838
7	JAZZ	Jazz Pharmaceuticals plc	11,194	$2,116,225
8	BMRN	Biomarin Pharmaceutical Inc This page	35,392	$1,999,294

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,999,294	35,392	+0.5%	Shares	Other	2026-05-13
2025-12-31	$2,092,411	35,208	-2.2%	Shares	Other	2026-02-11
2025-09-30	$1,949,435	35,994	-3.3%	Shares	Other	2025-11-10
2025-06-30	$2,046,807	37,235	-0.7%	Shares	Other	2025-08-12
2025-03-31	$2,650,733	37,498	-1.8%	Shares	Other	2025-05-12
2024-12-31	$2,509,111	38,173	-2.3%	Shares	Other	2025-02-13
2024-09-30	$2,745,457	39,059	-3.3%	Shares	Other	2024-11-13
2024-06-30	$3,325,061	40,387	+1066.2%	Shares	Other	2024-08-13
2020-09-30	$263,465	3,463	-3.3%	Shares	Other	2020-11-13
2020-06-30	$441,557	3,580	0.0%	Shares	Other	2020-08-05
2020-03-31	$302,510	3,580	—	Shares	Other	2020-05-13
No filing history on record for this holder in this stock.